课题基金 / 基金详情

PRECLINICAL MDL FOR LABELING, TRANSPLANT, & IMAGING OF DIFFERENTIAL HES CELLS

PRECLINICAL MDL FOR LABELING, TRANSPLANT, & IMAGING OF DIFFERENTIAL HES CELLS
用于标记、移植、
批准号:
7715659
负责人:
Alice F Tarantal
金额:
$8.13万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2009-04-30

项目摘要

项目成果

Alice F Tarantal的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的:细胞治疗是一种潜在的修复肾脏疾病损伤的技术。为了有效地开发这种方法,了解后肾的发育是至关重要的,特别是对于引导人类胚胎干细胞(HES)向肾前体细胞发展而言。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: Cellular therapy is a potential technique under study for repair of kidneys damaged by disease. In order to effectively develop such approaches, an understanding of the development of the metanephric kidney is essential, particularly for directing human embryonic stem (hES) cells towards renal precursors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program
  • 批准号:
    10889393
  • 项目类别:
  • 资助金额:
    $24.59万
  • 财政年份:
    2023
  • 负责人:
    Alice F Tarantal
  • 依托单位:
Coordination Component
  • 批准号:
    10773948
  • 项目类别:
  • 资助金额:
    $9.41万
  • 财政年份:
    2023
  • 负责人:
    Alice F Tarantal
  • 依托单位:
Resource Component
  • 批准号:
    10773950
  • 项目类别:
  • 资助金额:
    $59.53万
  • 财政年份:
    2023
  • 负责人:
    Alice F Tarantal
  • 依托单位:
Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program
  • 批准号:
    10555610
  • 项目类别:
  • 资助金额:
    $78.72万
  • 财政年份:
    2022
  • 负责人:
    Alice F Tarantal
  • 依托单位: